Cargando…

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer

SIMPLE SUMMARY: The evolution of colorectal cancer (CRC) is influenced by complex interactions between tumor cells and tumor-infiltrating lymphocytes (TILs). Optimized immunotherapies to boost the potential anti-tumor T-cell response are still needed in CRC. A good candidate is the inflammasome path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mutala, Linda Bilonda, Deleine, Cécile, Karakachoff, Matilde, Dansette, Delphine, Ducoin, Kathleen, Oger, Romain, Rousseau, Olivia, Podevin, Juliette, Duchalais, Emilie, Fourquier, Pierre, Thomas, Wassila El Alami, Gourraud, Pierre-Antoine, Bennouna, Jaafar, Brochier, Camille, Gervois, Nadine, Bossard, Céline, Jarry, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825767/ https://www.ncbi.nlm.nih.gov/pubmed/33430344 http://dx.doi.org/10.3390/cancers13020189

Ejemplares similares

The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status
por: Ott, Eva, et al.
Publicado: (2019)

Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy
por: Ducoin, Kathleen, et al.
Publicado: (2022)

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
por: Ducoin, Kathleen, et al.
Publicado: (2022)

The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
por: Barret, Jean-Marc, et al.
Publicado: (2021)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes
por: Marotte, L, et al.
Publicado: (2021)

HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation
por: Allard, Mathilde, et al.
Publicado: (2012)

Patient-centric synthetic data generation, no reason to risk re-identification in biomedical data analysis
por: Guillaudeux, Morgan, et al.
Publicado: (2023)

Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome
por: Montassier, Emmanuel, et al.
Publicado: (2020)

STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
por: Pons-Tostivint, Elvire, et al.
Publicado: (2021)

Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic EGFR-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent Treatments
por: Denis, Marc G, et al.
Publicado: (2020)

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine
por: Pons-Tostivint, Elvire, et al.
Publicado: (2022)

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
por: Vey, Norbert, et al.
Publicado: (2018)

New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples
por: Barnetche, Thomas, et al.
Publicado: (2008)

Draft Genome Sequence of Collimonas pratensis Strain PMB3(1), an Effective Mineral-Weathering and Chitin-Hydrolyzing Bacterial Strain
por: Picard, Laura, et al.
Publicado: (2020)

NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression
por: Simon, Priscilla S., et al.
Publicado: (2016)

Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis
por: Valès, Simon, et al.
Publicado: (2019)

PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment
por: Li, Jing, et al.
Publicado: (2014)

CD103(+)CD8(+) T(RM) Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
por: Corgnac, Stéphanie, et al.
Publicado: (2020)

Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC‐1 tumor‐bearing mice with PD‐1 blockade by modulating macrophage heterogeneity and the activation of CD8(+) T cells in the tumor microenvironment
por: Ni, Guoying, et al.
Publicado: (2021)

Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B(4)
por: Nouri, Khawla, et al.
Publicado: (2022)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

Differential Activation of CD8(+) Tumor-Specific Tc1 and Tc2 Cells by an IL-10-Producing Murine Plasmacytoma
por: Specht, Christoph, et al.
Publicado: (1998)

Intramolecular Hydrogen Bonds in Conformers of Quinine and Quinidine: An HF, MP2 and DFT Study
por: Bilonda, Mireille K., et al.
Publicado: (2017)

Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines
por: Sun, Liying, et al.
Publicado: (2018)

Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma
por: Cogdell, David, et al.
Publicado: (2011)

Erratum to “Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis” [EBioMedicine 49 (2019) 172–188]
por: Valès, Simon, et al.
Publicado: (2023)

DNA PLOIDY IN 1,2‐DIMETHYL‐HYDRAZINE‐INDUCED RAT TUMORS
por: Sano, Takeshi, et al.
Publicado: (1988)

An adverse tumor-protective effect of IDO1 inhibition
por: Kenski, Juliana C.N., et al.
Publicado: (2023)

Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2
por: Lafite, Pierre, et al.
Publicado: (2018)

Peripheral blood immune cell profiling of acute corneal transplant rejection
por: Hjortdal, Jesper, et al.
Publicado: (2022)

Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes
por: Marotte, Lucine, et al.
Publicado: (2020)

Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity‐modulated proton therapy breast cancer plans
por: Rana, Suresh, et al.
Publicado: (2019)

Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy
por: Rana, Suresh, et al.
Publicado: (2020)

The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?
por: Xu, Shouying, et al.
Publicado: (2021)

Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
por: Sonveaux, Pierre, et al.
Publicado: (2012)

Facile synthesis of cyclopentenone B(1)- and L(1)-type phytoprostanes
por: Guy, Alexandre, et al.
Publicado: (2015)

Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells
por: De Saedeleer, Christophe J., et al.
Publicado: (2012)

High-Density of FcγRIIIA(+) (CD16(+)) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis
por: Denis Musquer, Marie, et al.
Publicado: (2021)

SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
por: Deng, Chu-Xia
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_n8bsgckvn2cu3srqu0eiifsok9